SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-034985
Filing Date
2013-06-14
Accepted
2013-06-14 16:30:06
Documents
11
Period of Report
2013-04-30

Document Format Files

Seq Description Document Type Size
1 10-Q v347123_10q.htm 10-Q 445418
2 EXHIBIT 31.1 v347123_ex31-1.htm EX-31.1 9913
3 EXHIBIT 31.2 v347123_ex31-2.htm EX-31.2 10029
4 EXHIBIT 32.1 v347123_ex32-1.htm EX-32.1 4892
5 EXHIBIT 32.2 v347123_ex32-2.htm EX-32.2 4912
  Complete submission text file 0001144204-13-034985.txt   5911654

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT adxs-20130430.xml EX-101.INS 734711
7 XBRL TAXONOMY EXTENSION SCHEMA adxs-20130430.xsd EX-101.SCH 77650
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adxs-20130430_cal.xml EX-101.CAL 41243
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adxs-20130430_def.xml EX-101.DEF 358758
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE adxs-20130430_lab.xml EX-101.LAB 531265
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adxs-20130430_pre.xml EX-101.PRE 421690
Mailing Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 000-28489 | Film No.: 13914571
SIC: 2834 Pharmaceutical Preparations